Sovran Advisors »

Summit Therapeutics shares owned by Sovran Advisors

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Sovran Advisors from 13F filings

Historical chart of Sovran Advisors investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Sovran Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Sovran Advisors

Quarter filed Position value Share count Share price at filing
2025-06-30 $3.4M 150k 22.99
2025-03-31 $3.6M 147k 24.61
2024-12-31 $2.0M 117k 16.65